Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.
Unmasking IgAN: From Suspicion to Timely Diagnosis
Unmasking IgAN: From Suspicion to Timely Diagnosis
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Cutting-Edge Trials: TAVR for Small Aortic Annuli
Cutting-Edge Trials: TAVR for Small Aortic Annuli
New Hope for TAVR: Overcoming Challenges for Women & Patients With Small Annuli
New Hope for TAVR: Overcoming Challenges for Women & Patients With Small Annuli
Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data
Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
